Clovis: 2Q Earnings Snapshot

BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Thursday reported a loss of $120.4 million in its second quarter.

On a per-share basis, the Boulder, Colorado-based company said it had a loss of $2.27.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.70 per share.

The biopharmaceutical company posted revenue of $33 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $34.9 million.

Clovis shares have dropped 41% since the beginning of the year. The stock has dropped 76% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CLVS at

all right reserved for yahoo news

Get the latest news delivered to your inbox

Follow us on social media networks

PREV See the terrifying moments passengers leap overboard when their boat catches fire
NEXT Jernigan Capital: 2Q Earnings Snapshot